Back to Companies
Outlook Therapeutics, Inc.
OTLKNasdaqCIK: 0001649989
Outlook Therapeutics, Inc. (OTLK) shows 21 recent insider filings from 11 insiders, with all of them on the buy side. With $7.9M in purchases and $0 in sales, the recent tape is heavily weighted toward buying (a net purchase of $7.9M). Sukhtian Ghiath M. is the most active by dollar volume, and the single largest transaction was $41.7M by Sukhtian Ghiath M.. All figures are drawn from official SEC Form 3, 4, and 5 disclosures and update as new filings arrive.
Total Volume
$52.2M
Purchases
$7.9M
Sales
$0
Unique Insiders
11
Recent Insider Trades
21 loaded
| Aug 14 | OTLK Outlook Therapeutics, Inc. | Jahr Robert Charles | Chief Executive Officer, Director | Buy | $166.7K |
| Aug 14 | OTLK Outlook Therapeutics, Inc. | KENYON LAWRENCE A | Chief Financial Officer, Director | Buy | $111.1K |
| Aug 14 | OTLK Outlook Therapeutics, Inc. | Sukhtian Ghiath M. | Insider | Buy | $2.5M |
| Jul 29 | OTLK Outlook Therapeutics, Inc. | Sukhtian Faisal Ghiath | Director | Buy | $100.0K |
| Jul 23 | OTLK Outlook Therapeutics, Inc. | Jahr Robert Charles | Chief Executive Officer, Director | Award | $143.0K |
| Jul 23 | OTLK Outlook Therapeutics, Inc. | KENYON LAWRENCE A | Chief Financial Officer, Director | Award | $300.5K |
| Jun 3 | OTLK Outlook Therapeutics, Inc. | Haddadin Yezan Munther | Director | Buy | $24.1K |
| Jun 1 | OTLK Outlook Therapeutics, Inc. | Sukhtian Ghiath M. | Insider | Buy | $5.0M |
| May 27 | OTLK Outlook Therapeutics, Inc. | Sukhtian Faisal Ghiath | Director | Buy | $50.0K |
| May 27 | OTLK Outlook Therapeutics, Inc. | Haddadin Yezan Munther | Director | Buy | $15.0K |
| May 27 | OTLK Outlook Therapeutics, Inc. | THURMAN RANDY H | Director | Buy | $2.1K |
| May 27 | OTLK Outlook Therapeutics, Inc. | HILZINGER KURT J | Director | Buy | $176.5K |
| Oct 3 | OTLK Outlook Therapeutics, Inc. | Auffarth Gerd | Director | Award | $360.4K |
| Oct 3 | OTLK Outlook Therapeutics, Inc. | Gangolli Julian S | Director | Award | $298.2K |
| Oct 3 | OTLK Outlook Therapeutics, Inc. | HILZINGER KURT J | Director | Award | $394.3K |
| Oct 3 | OTLK Outlook Therapeutics, Inc. | Huang Andong | Director | Award | $354.7K |
| Oct 3 | OTLK Outlook Therapeutics, Inc. | Sukhtian Faisal Ghiath | Director | Award | $422.5K |
| Oct 3 | OTLK Outlook Therapeutics, Inc. | Haddadin Yezan Munther | Director | Award | $399.9K |
| Oct 3 | OTLK Outlook Therapeutics, Inc. | Haller Julia A | Director | Award | $360.4K |
| Oct 3 | OTLK Outlook Therapeutics, Inc. | THURMAN RANDY H | Director | Award | $298.2K |
| Jul 9 | OTLK Outlook Therapeutics, Inc. | Jahr Robert Charles | Insider | Award | $1.3M |
21 filings